Table 1 Characteristics of study patients
Women N = 4344 | Men N = 2773 | P-value | |
|---|---|---|---|
Demographics | |||
Mean age (years), mean (SD) | 70 (12) | 66 (12) | < 0.001 |
Medication (ATC), n (%) | |||
Lipid-lowering medication (C10) | 2310 (53) | 1400 (50) | 0.027 |
Other cardiac therapy e.g. antiarrhythmics, nitrates (C01) | 936 (22) | 429 (15) | < 0.001 |
ACE-inhibitors, Angiotensin II antagonists (C09) | 3531 (81) | 2330 (84) | 0.003 |
Diuretics (C03) | 1370 (32) | 538 (19) | < 0.001 |
Beta blockers (C07) | 2477 (57) | 1312 (47) | < 0.001 |
Calcium Channel Blockers (C08) | 2150 (49) | 1379 (50) | 0.85 |
Other antihypertensives (C02) | 114 (3) | 73 (3) | 0.97 |
Co-morbidity (ICD-10), n (%) | |||
Heart failure (I50) | 95 (2) | 31 (1) | < 0.001 |
Atrial fibrillation and flutter (I48) | 295 (7) | 207 (7) | 0.28 |
Plasma LDL-C level, mean (SD) | |||
All | 2.88 (0.88) | 2.85 (0.88) | < 0.001a |
With LLM | 2.75 (0.97) | 2.68 (0.98) | < 0.001a |
Without LLM | 3.03 (0.73) | 3.01 (0.73) | 0.25a |